Dyspepsia and Helicobacter pylori

British Medical Journal

Volumn 334, Issue 7583, 2007, Pages 41-43

  Shah, Rupal ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DYSPEPSIA; ENDOSCOPY; ERADICATION THERAPY; FECES ANALYSIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; NOTE; PEPTIC ULCER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SYMPTOMATOLOGY; UREA BREATH TEST;

BREATH TESTS; CLINICAL TRIALS; DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION;

EID: 33846195824     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39014.468900.BE     Document Type: Note

References (10)

1. British Society of Gastroenterology. Guidelines for the management of oesophageal and gastric cancer. London: BSG, 2002. (Available from www.bsg.org.uk.)
2. Lane JA, Murray LJ, Noble S, Egger M, Harvey IM, Donovan JL, et al. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial. BMJ 2006;332:199-204.
3. Chiba N, van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 2002;324:1012.
4. Labenz J, Blum AL, Bayerdorffer E, Meining A. Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
5. Harvey RF, Lane A, Murray LJ, Harvey IM, Donovan JI, Nair P. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project. BMJ 2004;328:1417.
6. Delaney B, Ford AC, Forman D, Moayyedi P, Qume M. Initial management strategies for dyspepsia (Cochrane review). Cochrane Database Syst Rev 2005;(4):CD001961.
7. National Institute for Health and Clinical Excellence. Managing dyspepsia in adults in primary care. London: NICE, 2004 (updated 2005). (Available from www.nice.org.uk.)
8. H pylori eradication in NSAID-associated ulcers. Drug Ther Bull 2005;43:37-40.
9. Hippisley-Cox J, Coupland C, Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;331:1310-6.
10. Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 2004;329:948.